Aarti Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

2,266.91

2,497.97

2,251.17

1,914.89

1,634.92

Operating profit

266.13

282.40

318.18

401.28

244.40

Interest

30.16

32.53

20.06

22.61

32.20

Gross profit

240.15

252.10

302.89

385.09

213.26

EPS (Rs)

15.43

16.50

21.06

27.65

58.23

Other income

4.18

2.23

4.77

6.42

1.06

Stock adjustment

26.77

-6.72

-77.94

-9.08

-53.94

Raw material

1,466.57

1,702.44

1,524.56

1,127.79

1,078.80

Power and fuel

-

-

-

-

-

Employee expenses

80.98

74.99

69.32

69.29

60.10

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

426.46

444.86

417.05

325.61

305.56

Provisions made

-

-

-

-

-

Depreciation

47.67

47.29

47.39

47.60

46.67

Taxation

50.60

52.00

60.50

80.00

39.30

Net profit / loss

141.88

152.81

195.00

257.71

135.67

Extra ordinary item

-

-

-

0.22

8.38

Prior year adjustments

-

-

-

-

-

Equity capital

91.94

92.60

92.60

93.20

23.30

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.74

11.31

14.13

20.96

14.95

GPM (%)

10.57

10.08

13.43

20.04

13.04

NPM (%)

6.25

6.11

8.64

13.41

8.29